Studies back Gen-Probe's prostate cancer gene diagnostic over PSA testing
This article was originally published in Clinica
Executive Summary
New studies have produced evidence to support the superiority of an investigational gene marker for prostate cancer, called PCA3, over the current gold standard prostate-specific antigen (PSA) serum marker for diagnosing the condition.